Specialty pharmaceutical and medical device company Delcath Systems Inc. (DCTH) said Thursday it plans to offer shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering. Delcath said the offering is subject to market and other conditions.
Delcath said it expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock and warrants offered in the public offering to cover over-allotments, if any.
The company expects that the proceeds of the offering will mainly be used for general corporate purposes.
Cowen and Company, LLC and Wedbush PacGrow Life Sciences are acting as joint book-runners for the offering. Roth Capital Partners is acting as co-manager for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.